143 related articles for article (PubMed ID: 25874936)
1. A protein deep sequencing evaluation of metastatic melanoma tissues.
Welinder C; Pawłowski K; Sugihara Y; Yakovleva M; Jönsson G; Ingvar C; Lundgren L; Baldetorp B; Olsson H; Rezeli M; Jansson B; Laurell T; Fehniger T; Döme B; Malm J; Wieslander E; Nishimura T; Marko-Varga G
PLoS One; 2015; 10(4):e0123661. PubMed ID: 25874936
[TBL] [Abstract][Full Text] [Related]
2. Correlation of histopathologic characteristics to protein expression and function in malignant melanoma.
Welinder C; Pawłowski K; Szasz AM; Yakovleva M; Sugihara Y; Malm J; Jönsson G; Ingvar C; Lundgren L; Baldetorp B; Olsson H; Rezeli M; Laurell T; Wieslander E; Marko-Varga G
PLoS One; 2017; 12(4):e0176167. PubMed ID: 28445515
[TBL] [Abstract][Full Text] [Related]
3. Feasibility study on measuring selected proteins in malignant melanoma tissue by SRM quantification.
Welinder C; Jönsson G; Ingvar C; Lundgren L; Baldetorp B; Olsson H; Breslin T; Rezeli M; Jansson B; Laurell T; Fehniger TE; Wieslander E; Pawlowski K; Marko-Varga G
J Proteome Res; 2014 Mar; 13(3):1315-26. PubMed ID: 24490776
[TBL] [Abstract][Full Text] [Related]
4. Proteomic profiling of human melanoma metastatic cell line secretomes.
Rocco M; Malorni L; Cozzolino R; Palmieri G; Rozzo C; Manca A; Parente A; Chambery A
J Proteome Res; 2011 Oct; 10(10):4703-14. PubMed ID: 21815687
[TBL] [Abstract][Full Text] [Related]
5. Large-scale proteomic characterization of melanoma expressed proteins reveals nestin and vimentin as biomarkers that can potentially distinguish melanoma subtypes.
Qendro V; Lundgren DH; Rezaul K; Mahony F; Ferrell N; Bi A; Latifi A; Chowdhury D; Gygi S; Haas W; Wilson L; Murphy M; Han DK
J Proteome Res; 2014 Nov; 13(11):5031-40. PubMed ID: 25322343
[TBL] [Abstract][Full Text] [Related]
6. Proteomic analysis of Tn-bearing glycoproteins from different stages of melanoma cells reveals new biomarkers.
Hoja-Łukowicz D; Szwed S; Laidler P; Lityńska A
Biochimie; 2018 Aug; 151():14-26. PubMed ID: 29802864
[TBL] [Abstract][Full Text] [Related]
7. Mass Spectrometry-Based Proteomic Characterization of Cutaneous Melanoma Ectosomes Reveals the Presence of Cancer-Related Molecules.
Surman M; Kędracka-Krok S; Hoja-Łukowicz D; Jankowska U; Drożdż A; Stępień EŁ; Przybyło M
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32331267
[TBL] [Abstract][Full Text] [Related]
8. Differential expression of cyclooxygenase-2 in metastatic melanoma affects progression free survival.
Panza E; De Cicco P; Ercolano G; Armogida C; Scognamiglio G; Anniciello AM; Botti G; Cirino G; Ianaro A
Oncotarget; 2016 Aug; 7(35):57077-57085. PubMed ID: 27494851
[TBL] [Abstract][Full Text] [Related]
9. Proteomic analysis of membrane rafts of melanoma cells identifies protein patterns characteristic of the tumor progression stage.
Baruthio F; Quadroni M; Rüegg C; Mariotti A
Proteomics; 2008 Nov; 8(22):4733-47. PubMed ID: 18942674
[TBL] [Abstract][Full Text] [Related]
10. Heterogenous S-100B protein expression patterns in malignant melanoma and association with serum protein levels.
Bánfalvi T; Udvarhelyi N; Orosz Z; Gergye M; Gilde K; Tímár J
Oncology; 2003; 64(4):374-9. PubMed ID: 12759535
[TBL] [Abstract][Full Text] [Related]
11. In-depth proteomic profiling of the uveal melanoma secretome.
Angi M; Kalirai H; Prendergast S; Simpson D; Hammond DE; Madigan MC; Beynon RJ; Coupland SE
Oncotarget; 2016 Aug; 7(31):49623-49635. PubMed ID: 27391064
[TBL] [Abstract][Full Text] [Related]
12. Comparative proteomic analysis of matched primary and metastatic melanoma cell lines.
Al-Ghoul M; Brück TB; Lauer-Fields JL; Asirvatham VS; Zapata C; Kerr RG; Fields GB
J Proteome Res; 2008 Sep; 7(9):4107-18. PubMed ID: 18698805
[TBL] [Abstract][Full Text] [Related]
13. Decreased expression of Apaf-1 with progression of melanoma.
Mustika R; Budiyanto A; Nishigori C; Ichihashi M; Ueda M
Pigment Cell Res; 2005 Feb; 18(1):59-62. PubMed ID: 15649154
[TBL] [Abstract][Full Text] [Related]
14. MDA-9 and GRP78 as potential diagnostic biomarkers for early detection of melanoma metastasis.
Guan M; Chen X; Ma Y; Tang L; Guan L; Ren X; Yu B; Zhang W; Su B
Tumour Biol; 2015 Apr; 36(4):2973-82. PubMed ID: 25480418
[TBL] [Abstract][Full Text] [Related]
15. Metastatic lesions with and without interleukin-18-dependent genes in advanced-stage melanoma patients.
Crende O; Sabatino M; Valcárcel M; Carrascal T; Riestra P; López-Guerrero JA; Nagore E; Mandruzzato S; Wang E; Marincola FM; Vidal-Vanaclocha F
Am J Pathol; 2013 Jul; 183(1):69-82. PubMed ID: 23707237
[TBL] [Abstract][Full Text] [Related]
16. Biomarker discovery in low-grade breast cancer using isobaric stable isotope tags and two-dimensional liquid chromatography-tandem mass spectrometry (iTRAQ-2DLC-MS/MS) based quantitative proteomic analysis.
Bouchal P; Roumeliotis T; Hrstka R; Nenutil R; Vojtesek B; Garbis SD
J Proteome Res; 2009 Jan; 8(1):362-73. PubMed ID: 19053527
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of matrix metalloproteinases, chemokines, and chemokine receptors relevant for metastasis in experimental models not an indication of lymph node metastases in human melanoma.
Otto K; Starz H; Becker JC; Schrama D
Arch Dermatol; 2007 Jul; 143(7):947-8. PubMed ID: 17638747
[No Abstract] [Full Text] [Related]
18. The human melanoma proteome atlas-Defining the molecular pathology.
Betancourt LH; Gil J; Kim Y; Doma V; Çakır U; Sanchez A; Murillo JR; Kuras M; Parada IP; Sugihara Y; Appelqvist R; Wieslander E; Welinder C; Velasquez E; de Almeida NP; Woldmar N; Marko-Varga M; Pawłowski K; Eriksson J; Szeitz B; Baldetorp B; Ingvar C; Olsson H; Lundgren L; Lindberg H; Oskolas H; Lee B; Berge E; Sjögren M; Eriksson C; Kim D; Kwon HJ; Knudsen B; Rezeli M; Hong R; Horvatovich P; Miliotis T; Nishimura T; Kato H; Steinfelder E; Oppermann M; Miller K; Florindi F; Zhou Q; Domont GB; Pizzatti L; Nogueira FCS; Horvath P; Szadai L; Tímár J; Kárpáti S; Szász AM; Malm J; Fenyö D; Ekedahl H; Németh IB; Marko-Varga G
Clin Transl Med; 2021 Jul; 11(7):e473. PubMed ID: 34323403
[TBL] [Abstract][Full Text] [Related]
19. Lymphangiogenesis and its relationship with lymphatic metastasis and prognosis in malignant melanoma.
Liu B; Ma J; Wang X; Su F; Li X; Yang S; Ma W; Zhang Y
Anat Rec (Hoboken); 2008 Oct; 291(10):1227-35. PubMed ID: 18561194
[TBL] [Abstract][Full Text] [Related]
20. Quantitative proteomic analysis for radiation-induced cell cycle suspension in 92-1 melanoma cell line.
Wang F; Bing Z; Zhang Y; Ao B; Zhang S; Ye C; He J; Ding N; Ye W; Xiong J; Sun J; Furusawa Y; Zhou G; Yang L
J Radiat Res; 2013 Jul; 54(4):649-62. PubMed ID: 23447694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
